Rigontec's Acquisition

Rigontec was acquired by Merck & Co. on September 06, 2017.

Rigontec is a biopharmaceutical company developing RNA-based immunotherapeutics for the treatment of cancer and viral diseases.…

Articles about Rigontec's Acquisition: